Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women

Author： Navarro M.A.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.42, Iss.1, 1997-01, pp. : 83-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

By Tsutsui S.  

Breast Cancer Research and Treatment, Vol. 71, Iss. 1, 2002-01 ,pp. : 67-75

Springer Publishing Company

Access to resources Recommend Favorite

Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2positive breast cancer in Japan

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1268-1274

Science Publishers

Access to resources Recommend Favorite

Long-Term Transvaginal Ultrasonographic Endometrial Follow-up in Postmenopausal Breast Cancer Patients with Tamoxifen Treatment

By Nahari C.   Tepper R.   Beyth Y.   Flex D.   Figer A.   Cohen I.  

Gynecologic Oncology, Vol. 74, Iss. 2, 1999-08 ,pp. : 222-226

Elsevier

Access to resources Recommend Favorite

Overexpression of Cyclin A Overrides the Effect of p53 Alterations in Breast Cancer Patients with Long Follow-up Time

By Bukholm I.R.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 2, 2003-07 ,pp. : 199-206

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Utility of Serial Serum c-erbB-2 Determinations in the Follow-up of Breast Cancer Patients

By Fehm T.   Gebauer G.   Jäger W.  

Breast Cancer Research and Treatment, Vol. 75, Iss. 2, 2002-09 ,pp. : 97-106

Springer Publishing Company

Access to resources Recommend Favorite